ARYLATION OF MGMT BY PARP IS REQUIRED FOR MGMT MEDIATED TEMOZOLOMIDE-INDUCED O6-METHYLGUANINE REPAIR: A NOVEL MECHANISM OF MGMT ACTION

被引:0
|
作者
Wu, Shaofang [1 ]
Gao, Feng [1 ]
Koul, Dimpy [1 ]
Yung, Alfred [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DRES-02
引用
收藏
页码:71 / 72
页数:2
相关论文
共 50 条
  • [1] PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma
    Wu, Shaofang
    Li, Xiaolong
    Gao, Feng
    de Groot, John F.
    Koul, Dimpy
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2021, 23 (06) : 920 - 931
  • [2] O6-methylguanine as the junction of MGMT and PARP1-mediated repair pathways
    Cropper, Jodie D.
    Alimbetov, Dauren S.
    Brown, Kevin T.
    Robles, Andrew
    Likhotvorik, Rostislav I.
    Guerra, James T.
    Chen, Yidong
    Kwon, Youngho
    Kurmasheva, Raushan T.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] PARP1-MGMT complex underpins pathway crosstalk in O6-methylguanine repair
    Jodie D. Cropper
    Dauren S. Alimbetov
    Kevin T. G. Brown
    Rostislav I. Likhotvorik
    Andrew J. Robles
    James T. Guerra
    Boxue He
    Yidong Chen
    Youngho Kwon
    Raushan T. Kurmasheva
    Journal of Hematology & Oncology, 15
  • [4] PARP1-MGMT complex underpins pathway crosstalk in O6-methylguanine repair
    Cropper, Jodie D.
    Alimbetov, Dauren S.
    Brown, Kevin T. G.
    Likhotvorik, Rostislav I.
    Robles, Andrew J.
    Guerra, James T.
    He, Boxue
    Chen, Yidong
    Kwon, Youngho
    Kurmasheva, Raushan T.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [5] O6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) PROMOTER METHYLATION STATUS AND THE INCIDENCE OF TEMOZOLOMIDE-INDUCED HEMATOLOGIC TOXICITY: AN ASSOCIATION STUDY
    Strohbusch, Alyssa
    Pound, Heather
    Regis, Patrick
    Cavaliere, Robert
    NEURO-ONCOLOGY, 2020, 22 : 135 - 135
  • [6] Inhibition of O6-methylguanine DNA methyltransferase (MGMT) in solid tumors by lomeguatrib
    Sabharwal, A.
    Watson, A. J.
    Bojanic, S.
    Kerr, R. S.
    Soonawalla, Z.
    Leung, H.
    King, A.
    Miller, A.
    Margison, G. P.
    Middleton, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Efficacy of Temozolomide in a Central Nervous System Relapse of Neuroblastoma With O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation
    Yamada, Ai
    Moritake, Hiroshi
    Shimonodan, Hidemi
    Yokogami, Kiyotaka
    Takeshima, Hideo
    Marutsuka, Kousuke
    Nunoi, Hiroyuki
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (01) : E38 - +
  • [8] Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
    Hegi, Monika E.
    Liu, Lili
    Herman, James G.
    Stupp, Roger
    Wick, Wolfgang
    Weller, Michael
    Mehta, Minesh P.
    Gilbert, Mark R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4189 - 4199
  • [9] O6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) PROMOTER METHYLATION IN PRIMITIVE NEUROECTODERMAL BRAIN TUMOR (PNET) CORRELATES WITH MGMT RNA EXPRESSION AND SENSITIVITY OF PNET CELLS TO TEMOZOLOMIDE
    von Bueren, Andre
    Faoro, Denis
    Shalaby, Tarek
    Huerlimann, Marie-Louise
    Arnold, Luzia
    Gerber, Nicolas
    Haybaeck, Johannes
    Mittelbronn, Michel
    Hegi, Monika
    Rutkowski, Stefan
    Grotzer, Michael
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 825 - 825
  • [10] Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)
    Yousefi, Yasamin
    Nejati, Reza
    Eslahi, Atiye
    Alizadeh, Farzaneh
    Farrokhi, Shima
    Asoodeh, Ahmad
    Mojarrad, Majid
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (01) : 129 - 135